GAiT would like to thank all who organized #CGTmfg19 Manufacturing Workshop this week. It was a very interesting and practically useful event.
Today we are organizing shipping of materials for the Quality Round. If you are participating we need you to compete steps 1-5 this week please so we can ship on schedule.
Participating in the Quality Round? We will need you to complete steps 1-5 in the Data Portal if we are to ship materials to you in April. If you have already completed these steps, your invoice will be with you shortly.
The report from the ISCBI workshop, held in collaboration GAiT and the Harvard Stem Cell Institute, Boston 2017 has been accessed for publication in STEM CELLS and should shortly be available to read online with Article ID: STEM3003.
GAiT is attending @CGTCatapult Manufacturing Workshop. Recommended reading is 2019 'Logistics by Design' paper https://t.co/oEHIX4IGJE … A lot to consider when it comes to identifying and solving iPSC manufacturing challenges.
5 of 16 Participants have already completed the first 5 steps of the entire Quality Round process (using the newly activated Data Portal at https://t.co/1WYwnFiXq7 ) . We are happy to see people find it easy to use.
The Quality Round Data Portal is now live. Participants can enter their shipping and billing information and download the Quality Round Data Portal for review.
GAiT is co-hosting a PSC Manufacturing Meeting at USC in Los Angeles 30 JUN 2019. If you are attending ISSCR2019 you might want to stay extra day to participate.
Thanks to co-hosts @ISCTglobal @CIRMnews @HESI_Global & ISCBI
GAiT is gearing up for the iPSC Quality Round it is organising with @NIBSC_MHRA, @STEMCELLTech and @CiRA_KU_E (Kyoto University). Quality Round Participants will be able to access the new Quality Round Data Portal this Friday 08 MARCH 2019 when it goes live.
Watch our Webinar Recording with Jacqueline Barry, Chief Clinical Officer at @CGTCatapult as she discusses ‘Regulatory Strategies to Implement your Manufacturing Processes’. Click here https://t.co/fOH6H0X8Fs #CellularTherapy #GeneTherapy #CellSeriesUS19
An upcoming trial in Japan will mark the first time that induced pluripotent stem (iPS) cells have been used to treat spinal-cord injuries.
‘Reprogrammed’ stem cells to treat spinal-cord injuries for the first time
Approval from Japanese regulators means that trials of induced pluripotent stem cells can begin later this year.
A number of experts from @CGTCatapult will be sharing their knowledge and experience in manufacturing cell and gene therapies at this year’s Cell and Gene Therapy Manufacturing Workshop, 11-12 March, London #manufacturing #GMPmanufacturing #CGTmfg19 - https://t.co/5VgUJ1jaUG
One week left for #ISCT2019 early registration rates! Prices go up Feb 23. Countdown is on until we meet in Melbourne! Register Now: https://t.co/JzUkyhtEY1
GAiT will speak on defining and assessing Quality for clinical-grade iPSCs at the International Society for Cell and Gene Therapy's Conference (ISCT2019) in Melbourne Friday, 31 MAY 2019 15:45-17:00 AEST.
MHRA announces contingency legislation covering regulation of medicines and medical devices in a no-deal Brexit scenario #regulation #regulatorynews #Brexit -
Contingency legislation covering regulation of medicines and medical devices in a no deal scenario
Legislation has been published which, in the event of the UK leaving the EU with no agreement, will cover the regulation of medicines, medical devices...
.@CGTCatapult's clinical trials database shows that there are 85 cell and gene therapy clinical trials ongoing in the UK #celltherapy #genetherapy #clinical trials - https://t.co/XkFKkiJL7K
We have now placed the audio and slides from the Donor Consent workshop up for members on the GAiT website (https://t.co/b4jQnk0Uxb ). Thanks again to @CCRM_ca 's Siofradh McMahon for very valuable input and indeed to all those who participated. #GAiT2019 #CCRM